Anebulo Pharmaceuticals ANEB Cash Flow Statement (2020-2025)

OTC ANEB

$0.35 -0.05 (-12.50%)

At close: Aug 19, 2026 · 4:00 PM EDT

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2020	Sep2020	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating Activities
Net Income (Quarter)				-0.56M	-2.47M	-1.55M	-3.47M	-5.65M	-4.55M	-2.97M	-3.94M	-3.20M	-7.18M	-3.05M	-2.82M	-1.95M	-1.40M	-2.49M	-2.68M	-2.04M	-2.24M	-3.63M	-2.55M
Share-based Compensation (Quarter)				0.05M	0.02M	0.03M	0.09M	0.13M	0.23M	0.20M	0.20M	0.20M	0.22M	0.20M	0.20M	0.20M	0.16M	0.30M	0.60M	1.60M	0.30M	1.50M	0.20M
Cash from Operations (Quarter)				-0.83M	-3.50M	-0.78M	-1.20M	-1.46M	-2.00M	-2.03M	-2.61M	-2.19M	-2.85M	-2.73M	-1.81M	-1.50M	-2.05M	-1.69M	-1.41M	-1.60M	-1.65M	-1.27M	-1.31M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter)																0.06M	0.06M	0.06M	0.06M	0.25M	0.02M	0.02M	0.02M
Change in Working Capital
Change in Account Payables (Quarter)				-0.00M	0.03M	0.38M	-0.45M	0.04M	0.30M	-0.11M	0.07M	0.22M	-0.04M	0.03M	-0.25M	0.07M	-0.23M	0.10M	0.03M	0.15M	-0.20M	0.38M	-0.05M
Change in Accured Expenses (Quarter)				0.15M	-0.08M	-0.02M	-0.11M	-0.00M	0.13M	0.04M	0.85M	-0.11M	-0.39M	-0.38M	0.54M	-0.07M	-0.52M	0.21M	0.24M	-0.44M	0.15M	0.09M	0.57M
Financing Activities
Other financing activities (Quarter)										0.05M
Change in Capital Stock
Shares Issued (Quarter)				1.59M	0.60M	0.60M	0.08M	1.48M	1.91M	1.90M	2.06M	0.66M	2.05M	2.05M	2.37M	0.71M	2.32M	2.32M	2.57M	1.37M	3.22M	1.92M	2.02M
Net Equity Issued and Repurchased (Quarter)										6.65M
Misc.
Cash from Financing Activities (Quarter)					20.18M					6.70M	-0.25M		-0.07M							-0.12M
Change in Cash (Quarter)				0.83M	16.68M	-0.78M	-1.20M	-1.46M	-2.00M	4.67M	-2.86M	-2.19M	-2.92M	-2.73M	-1.88M	-1.50M	-2.05M	-1.69M	13.59M	-1.72M	-1.65M	-1.27M	-1.31M
Free Cash Flow (Quarter)				-0.83M	-3.50M	-0.78M	-1.20M	-1.46M	-2.00M	-2.03M	-2.61M	-2.19M	-2.85M	-2.73M	-1.81M	-1.50M	-2.05M	-1.69M	-1.41M	-1.60M	-1.65M	-1.27M	-1.31M
Net Cash Flow (Quarter)				-0.83M	16.68M	-0.78M	-1.20M	-1.46M	-2.00M	4.67M	-2.86M	-2.19M	-2.92M	-2.73M	-1.81M	-1.50M	-2.05M	-1.69M	-1.41M	-1.72M	-1.65M	-1.27M	-1.31M

Anebulo Pharmaceuticals (ANEB)

OTC: ANEB

$0.35 ▼ -0.05 (-12.50%)

Aug 19, 2026 · 4:00 PM EDT